Examines the presence of neutralizing antibodies that negate the effect of Betaseron (interferon beta-1b) in the treatment of multiple sclerosis. Study of the Interferon Beta MS Study Group and the British Columbia MS/MRI Analysis Group; Classification of the patients to be tested.
No Comments.